Skip to main content
Clinical Trials/NL-OMON37991
NL-OMON37991
Completed
Not Applicable

Effect of renal sympathetic denervation on renal and overall sympathetic output in patients with therapy resistant hypertension - Effect of renal sympathetic denervation on sympathetic nervous activity

Academisch Medisch Centrum0 sites30 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Therapy resistant hypertension
Sponsor
Academisch Medisch Centrum
Enrollment
30
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients aged 40\-70 years receiving RSD for therapy resistant hypertension, defined as daytime ABPM\*150/100 mmHg despite the use of 3 or more anti\-hypertensive drugs including or with intolerance to a diuretic.;No evidence of secondary hypertension (renal artery stenosis, pheochromocytoma, primary aldosteronism and hyper\- or hypothyroidism have to be excluded prior to the intervention). ;Normal renal anatomy, single renal artery bilaterally.;Able to provide informed consent. ;Willingness to participate.

Exclusion Criteria

  • Renal insufficiency (eGFR\<45 ml/min) or proteinuria\>1 gram/24 hrs.;Pacemaker or ICD device;Atrial fibrillation;Diabetes Mellitus type 1;Unstable weight 3 months prior to inclusion;Pregnancy ;Treatment of DM type 2 with insulin, PPARγ\-agonists or SU\-dervatives (for clamp experiment only)

Outcomes

Primary Outcomes

Not specified

Similar Trials